Literature DB >> 9918352

Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees.

A Lazzarini1, A S Walters, K Hickey, G Coccagna, E Lugaresi, B L Ehrenberg, D L Picchietti, M F Brin, E S Stenroos, T Verrico, W G Johnson.   

Abstract

Restless legs syndrome (RLS) can occur with an autosomal-dominant mode of inheritance. To determine if there are distinguishing features of RLS pedigrees which might clarify molecular mechanisms of pathogenesis, five pedigrees with 81 affected members were analyzed for age of onset, sex ratio, and transmission pattern. One-factor analysis of variance of ages of onset between generations was carried out, and segregation ratios were calculated for each generation. These kindreds showed an autosomal-dominant mode of inheritance and a male:female ratio of 1:1.4 (p = 0.15). One of the five analyzed pedigrees shows some evidence of reduced penetrance. In two of the five analyzed pedigrees, there is statistical support for anticipation (p<0.05). These variations in penetrance and anticipation suggest possible genetic heterogeneity.

Entities:  

Mesh:

Year:  1999        PMID: 9918352     DOI: 10.1002/1531-8257(199901)14:1<111::aid-mds1018>3.0.co;2-9

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q.

Authors:  Norman Kock; Biljana Culjkovic; Susanna Maniak; Karla Schilling; Birgitt Müller; Christine Zühlke; Laurie Ozelius; Christine Klein; Peter P Pramstaller; Patricia L Kramer
Journal:  Am J Hum Genet       Date:  2002-07       Impact factor: 11.025

Review 2.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

Review 3.  Genetic aspects of restless legs syndrome.

Authors:  V Dhawan; M Ali; K R Chaudhuri
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

4.  Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate.

Authors:  Irene Pichler; Fabio Marroni; Claudia Beu Volpato; James F Gusella; Christine Klein; Giorgio Casari; Alessandro De Grandi; Peter P Pramstaller
Journal:  Am J Hum Genet       Date:  2006-08-14       Impact factor: 11.025

5.  Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q.

Authors:  A Desautels; G Turecki; J Montplaisir; A Sequeira; A Verner; G A Rouleau
Journal:  Am J Hum Genet       Date:  2001-11-06       Impact factor: 11.025

6.  Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p.

Authors:  Shenghan Chen; William G Ondo; Shaoqi Rao; Lin Li; Qiuyun Chen; Qing Wang
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

7.  Ropinirole in restless legs syndrome and periodic limb movement disorder.

Authors:  Daniel Erichsen; Raffaelle Ferri; David Gozal
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

8.  MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.

Authors:  Angela Roco; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Elena García-Martín; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2012-09-22       Impact factor: 3.575

Review 9.  Genetics of restless legs syndrome.

Authors:  Juliane Winkelmann
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 10.  Restless legs syndrome: an update on treatment options.

Authors:  Anthony H V Schapira
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.